Vickie Y. Jo

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff et al. · Clinical Cancer Research · 2020 · 342 citations · Full text

Malignancy Risk for Fine-Needle Aspiration of Thyroid Lesions According to The Bethesda System for Reporting Thyroid Cytopathology

Vickie Y. Jo, Edward B. Stelow, Simone M. Dustin et al. · American Journal of Clinical Pathology · 2010 · 328 citations · Full text

Pathology, Oncology, Fine-needle Aspiration +18

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

Jonathan D. Schoenfeld, Glenn J. Hanna, Vickie Y. Jo et al. · JAMA Oncology · 2020 · 326 citations · Full text

Clinically Relevant Molecular Subtypes in Leiomyosarcoma

Xiangqian Guo, Vickie Y. Jo, Anne M. Mills et al. · Clinical Cancer Research · 2015 · 149 citations · Full text

Recurrent Rearrangement of the PHF1 Gene in Ossifying Fibromyxoid Tumors

Samuel Gebré‐Medhin, Karolin H. Nord, Emely Möller et al. · American Journal Of Pathology · 2012 · 146 citations · Full text

Fibrosis, Pathology, Recurrent Rearrangement +4